Results 251 to 260 of about 138,640 (301)

Acute heart failure in patients with hematologic malignancies: A nationwide analysis 2016-2021. [PDF]

open access: yesSAGE Open Med
Prashanth Sivasubramanian B   +12 more
europepmc   +1 more source

Next-generation CAR-T and CAR-NK cell therapies in hematologic malignancies: engineering for persistence, specificity, and safety. [PDF]

open access: yesDiscov Oncol
Al-Khreisat MJ   +8 more
europepmc   +1 more source

Hematologic Malignancies

Hematology/Oncology Clinics of North America, 2020
Radiation therapy plays a critical role in the management of a wide range of hematologic malignancies. The optimal radiation dose and target volume, and safe and effective ways of integrating radiation with systemic agents, vary depending on the histologic subtypes, stage at presentation, patient performance status, response to systemic therapy if ...
Yolanda D, Tseng, Andrea K, Ng
openaire   +3 more sources

Hematological malignancies

The FASEB Journal, 1997
The present cure rate for leukemia and lymphoma represents one of the success stories of modern cancer therapy. However, treatments remain toxic, expensive, and ineffective for many patients. There is therefore considerable interest in exploring gene therapies for these disorders. To date, four major strategies have been adopted:
openaire   +2 more sources

Malignant Hematology

2012
The hematologic neoplasms include lymphoproliferative disorders (eg, chronic lymphocytic leukemia [CLL]/small lymphocytic lymphoma [SLL], large granular lymphocyte leukemia, hairy cell leukemia [HCL], Hodgkin lymphoma, non-Hodgkin lymphoma), plasma cell disorders (multiple myeloma, light chain amyloidosis ...
openaire   +1 more source

Hematologic Malignancies

2023
Daniel R. Richardson, Carolyn Mulroney
openaire   +2 more sources

Home - About - Disclaimer - Privacy